Advanced Physician Solutions Recalls Sodium Hyaluronate Vials Due to Sterility Concerns
Advanced Physician Solutions is recalling 21 vials of Sodium Hyaluronate Injectable due to a lack of assurance of sterility. The product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility in an injectable product corresponds to a severity score of 4 (Severe).
Plain-English summary
Advanced Physician Solutions, Inc. is recalling 21 vials of Sodium Hyaluronate (Sterile Water) 2.5 ML Vial 20MG/ML Injectable. The recall is being conducted because of a lack of assurance of sterility in the product.
The affected product was manufactured by Advanced Compounding Pharmacy located in North Hollywood, California. The recall covers all lots of the product, which was distributed nationwide.
Consumers and healthcare providers should stop using the recalled product immediately. They should contact Advanced Physician Solutions, Inc. for further instructions on how to return or dispose of the product.
The recalled product
- Product
- SODIUM HYALURONATE (STERILE WATER) 2.5 ML VIAL 20MG/ML INJECTABLE, Advanced Compounding Pharmacy, 7225 Fulton Ave., North Hollywood, CA 91605
- Manufacturer
- Advanced Physician Solutions, Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 21
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Advanced Physician Solutions, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Advanced Physician Solutions, Inc.
See all →- SevereAdvanced Compounding Pharmacy Recalls Glycerin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Nanpyridoxine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Injectable Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Sodium Hyaluronate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereAdvanced Pharma Recalls Phenylephrine Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Phenylephrine HCl Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Hydromorphone Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Esmolol HCl Injectable Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SevereAdvanced Pharma Recalls Phenylephrine HCl Injectable Syringes for Sterility Concerns
FDA (Drugs) · 2019-03-27